GovChime
Notice ID: 5387ce6eb59542bfad9637f14466f45cCombined Synopsis/SolicitationArchived

Subject Matter Expert Consultant for Drug Metabolism Pharmacokinetics [DMPK]

Archived on September 6, 2025. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
12:00 PM EDT
Posted
August 8, 2025
Notice type
Combined Synopsis/Solicitation
Set-aside
Total Small Business Set-Aside (FAR 19.5)
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIDA
Place of performance
Bethesda
Last updated
Nov 10, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
75N95025Q00250
Notice ID
5387ce6eb59542bfad9637f14466f45c

Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. The Government reserves the right to make one award, multiple awards, or no awards as a result of this solicitation. This acquisition is for a commercial item or service and is conducted under the authority of the FAR Part 13 Simplified Acquisition Procedures; and FAR Part 12 Acquisition of Commercial Items and is expected not to exceed the simplified acquisition threshold. This acquisition is being conducted using set-aside competition for any small business concerns. The solicitation number is 75N95025Q00250 and the solicitation is issued as a Request for Quotation (RFQ). Please see the attachments for more details.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Documents

Files (7)

  • Attachment 3 - Electronic Invoicing Instructions.pdf

    207 KBAdded in Combined Synopsis/Solicitation version 3Posted
    Download
  • Solicitation_RFQ_75N95025Q00250.docx

    29 KBAdded in Combined Synopsis/Solicitation version 1Posted
    Download
  • Attachment 1_SOW.doc

    94 KBAdded in Combined Synopsis/Solicitation version 1Posted
    Download
  • Attachment 2 - Additional Terms and Conditions.docx

    22 KBAdded in Combined Synopsis/Solicitation version 1Posted
    Download
  • Attachment 2 - Additional Terms and Conditions_FAR 52.212-5 (May 2022).pdf

    2.9 MBAdded in Combined Synopsis/Solicitation version 1Posted
    Download
  • Attachment 4 - Price Template.xlsx

    13 KBAdded in Combined Synopsis/Solicitation version 1Posted
    Download
  • Attachment 5_TechEvalCriteria.docx

    41 KBAdded in Combined Synopsis/Solicitation version 1Posted
    Download

Lifecycle

  1. 1
    Version 1Combined Synopsis/SolicitationArchived

    Subject Matter Expert Consultant for Drug Metabolism Pharmacokinetics [DMPK]

    Notice 0ff187a8197e4803a067d3cf0b2a41fd on SAM.gov

  2. 3
    Version 3Combined Synopsis/SolicitationArchivedCurrent

    Subject Matter Expert Consultant for Drug Metabolism Pharmacokinetics [DMPK]

    Notice 5387ce6eb59542bfad9637f14466f45c on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N95025Q00250

Archive Date

Sep 6, 2025